Correlation Between PDS Biotechnology and Myriad Genetics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both PDS Biotechnology and Myriad Genetics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining PDS Biotechnology and Myriad Genetics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between PDS Biotechnology Corp and Myriad Genetics, you can compare the effects of market volatilities on PDS Biotechnology and Myriad Genetics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in PDS Biotechnology with a short position of Myriad Genetics. Check out your portfolio center. Please also check ongoing floating volatility patterns of PDS Biotechnology and Myriad Genetics.

Diversification Opportunities for PDS Biotechnology and Myriad Genetics

0.64
  Correlation Coefficient

Poor diversification

The 3 months correlation between PDS and Myriad is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding PDS Biotechnology Corp and Myriad Genetics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Myriad Genetics and PDS Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on PDS Biotechnology Corp are associated (or correlated) with Myriad Genetics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Myriad Genetics has no effect on the direction of PDS Biotechnology i.e., PDS Biotechnology and Myriad Genetics go up and down completely randomly.

Pair Corralation between PDS Biotechnology and Myriad Genetics

Given the investment horizon of 90 days PDS Biotechnology Corp is expected to generate 1.68 times more return on investment than Myriad Genetics. However, PDS Biotechnology is 1.68 times more volatile than Myriad Genetics. It trades about -0.05 of its potential returns per unit of risk. Myriad Genetics is currently generating about -0.16 per unit of risk. If you would invest  169.00  in PDS Biotechnology Corp on December 28, 2024 and sell it today you would lose (44.00) from holding PDS Biotechnology Corp or give up 26.04% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

PDS Biotechnology Corp  vs.  Myriad Genetics

 Performance 
       Timeline  
PDS Biotechnology Corp 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days PDS Biotechnology Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Myriad Genetics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Myriad Genetics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

PDS Biotechnology and Myriad Genetics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with PDS Biotechnology and Myriad Genetics

The main advantage of trading using opposite PDS Biotechnology and Myriad Genetics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if PDS Biotechnology position performs unexpectedly, Myriad Genetics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will offset losses from the drop in Myriad Genetics' long position.
The idea behind PDS Biotechnology Corp and Myriad Genetics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios